F E A T U R E S
Defusing Violent and Aggressive Behavior in the Long-Term Care Setting
Jeannette Wick and Cecilia Reid
A growing problem in long-term care facilities, violent and aggressive resident behavior can be controlled with carefully designed prevention and treatment plans.
Profile: Jan Allen
David Buerger
Incoming ASCP President Jan Allen is both professionally respected and universally liked. Her secret lies in her powerful commitment to long-term care pharmacy for all the right reasons.
New Developments in Federal Fraud and Abuse Law: What Every Consultant Pharmacist Needs to Know
Margit Nahra
The legal and regulatory climate surrounding consultant pharmacy is changing fast, and pharmacists who hope to steer clear of violations will have to step up their efforts to understand the laws affecting their practices.
1997 ASCP Policy Statements and Guidelines
A listing of the official policy statements recommended by ASCP's four outstanding 1996-97 councils and approved by the ASCP Board of Directors during its meeting in July.
ASCP's 28th Annual Meeting and Exhibition
A complete "map" of events and opportunities at what promises to be the biggest and best ASCP Annual Meeting ever.
|
C O N T E N T S
October 1997/Volume 12, Number 10
|
About the artist: This month's exuberant cover painting, "Ribbons Aplenty," captures the color and excitement of Maryland's annual Montgomery County Fair. The striking watercolor is the work of Edward Longley, a retired University of Maryland art teacher and resident of Leisure World, a retirement community in Silver Spring, Maryland.
|
Research and Reports
Identification of Elderly Nursing Facility Residents at High Risk for Drug-Related Problems
Michelle Fouts, Joseph Hanlon, Carl Pieper, Eleanor Perfetto, Janice Feinberg
The authors performed a survey and a retrospective review of medical records to identify potential risk factors for drug-related problems in elderly nursing facility residents.
SSRI Withdrawal Syndrome
Penny A. Skaehill, E.B. Welch
The authors present case studies and review symptoms associated with discontinuation of selective serotonin reuptake inhibitors and discuss ways to prevent these symptoms or reduce their intensity.
|